Updated results from the BRUIN study: pirtobrutinib in the treatment of MCL

Updated results of the BRUIN trial: pirtobrutinib in R/R MCLПодробнее

BRUIN study: updated two-year subgroup analysis of pirtobrutinib for BTKi pre-treated MCLПодробнее

BRUIN study cohort update: pirtobrutinib for patients with MCLПодробнее

Updates from the Phase I/II BRUIN study: pirtobrutinib in CLLПодробнее

Updates from the BRUIN study – long-term safety of pirtobrutinib in R/R MCLПодробнее

Efficacy of pirtobrutinib in patients with R/R MCL previously treated with a covalent BTKiПодробнее